Volume 11 Supplement 1
7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Meeting abstracts
Publication of this supplement has been funded by the International congress on autoinflammatory disease (ISSAID) 2013. Abstracts are based on presentations made at the conference from ISSAID 2013.
7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID). Go to conference site.
Lausanne, Switzerland22-26 May 2013
Page 2 of 6
-
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A51
-
P01-049 – Assessment of vascular function in systemic JIA
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A52 -
P01-050 – Anakinra in systemic JIA: single center experience
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A53 -
PW01-001 – Pyrin-PSTPIP1 relation during cell migration
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A54 -
PW01-002 – Colchicine resistant FMF in Turkish children
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A55 -
PW01-003 – Frequency of MEFV mutations in Turkish population
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A56 -
PW01-004 – The sequence analysis in E148Q homozygous patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A57 -
PW01-005 – Effects of placebo and colchicine on FMF patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A58 -
PW01-006 – The effect of colchicine on physical growth in FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A59 -
PW01-007 – Colchicine brand switching in FMF patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A60 -
PW01-008 – The inflammasome and secretory pathways in FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A61 -
PW01-009 – Markers of inflammation in adult FMF patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A62 -
PW01-010 – The effect of pregnancy on disease course in FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A63 -
PW01-011 – Exertional leg pain and spondyloarthropathy on FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A64 -
PW01-012 – Canakinumab in patients with FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A65 -
PW01-013 – Localization of alternative pyrin isoforms
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A66 -
PW01-014 – MEFV methylation analysis in FMF and JRA diseases
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A67 -
PW01-015 – Canakinumab in adults with colchicin resistant FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A68 -
PW01-016 – Are different disease subtypes present in FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A69 -
PW01-017 – Urine MMP-3 level as a biomarker for in FMF attack
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A70 -
PW01-018 – Circulating endothelial biomarkers in FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A71 -
PW01-019 – MEFV gene mutations in 53 periodic fever patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A72 -
PW01-020 – MEFV mutations carrier rate in Central Europe
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A73 -
PW01-021 – The phenotype of FMF due to deletion M694
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A74 -
PW01-022 – Dissociation between CRP and SAA in FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A75 -
PW01-023 – Ex vivo PBMC cytokine profile in FMF patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A76 -
PW01-024 – Phenotypic analysis of a MEFV negative FMF cohort
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A77 -
PW01-025 – Definition of colchicine resistance in FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A78 -
PW01-026 – Validation of pediatric diagnostic criteria in FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A79 -
PW01-027 – Predictors and survival of FMF related amyloidosis
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A80 -
PW01-028 – Developing a new severity score for FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A81 -
PW01-029 – Relationship between apoptotic alterations and inflammation in familial Mediterranean fever
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A82 -
PW01-030 – Pulmonary manifestations of FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A83 -
PW01-031 – Treatment of FMF in middle and old age
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A84 -
PW01-032 – FMF-like state: genetic factors unrelated to MEFV
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A85 -
PW01-033 – Phenotype – genotype in Armenian children with FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A86 -
PW01-034 – Clinical-genetic investigation of FMF in Armenia
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A87 -
PW01-035 – Mutations in PB30.2D and complexing with caspase-1
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A88 -
PW01-036 – Renal replacement therapy in patients with FMF
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A89 -
PW01-037 – Amyloidosis probability depending on MEFV type
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A90 -
PW01-038 – Genomewide association study of Still’s disease
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A91 -
PW01-039 – Long-term efficacy of anakinra in SoJIA patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A92 -
PW01-040 – Definition of polymorphism C3435T MDR1 gene in JIA
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A93 -
OR5-001 – Characterization of tonsil infiltration in PFAPA
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A94 -
OR5-002 – In vitro studies in Schnitzler’s syndrome
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A95 -
OR6-001 - S100A12 as pro-inflammatory TLR4 ligand
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A96 -
OR6-002 – Thromboembolism in autoinflammatory syndromes
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A97 -
OR6-003 – Prospective evaluation of PFAPA patients
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A98 -
OR6-004 – MRP8/14 promote MSU-crystal induced inflammation
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A99 -
OR6-005 – Cystine crystals activate inflammasomes
Citation: Pediatric Rheumatology 2013 11(Suppl 1):A100
Official journal of
Annual Journal Metrics
-
2022 Citation Impact
2.5 - 2-year Impact Factor
3.0 - 5-year Impact Factor
1.035 - SNIP (Source Normalized Impact per Paper)
0.732 - SJR (SCImago Journal Rank)2022 Speed
12 days submission to first editorial decision for all manuscripts (Median)
108 days submission to accept (Median)2022 Usage
901,346 downloads
750 Altmetric mentions